Checkpoint Therapeutics in Milano 12 September 2024. Research Notes from 3 brokerage firms
Checkpoint Therapeutics, Inc. (CKPT) Rating: Buy Joseph Pantginis, Ph.D. 646-975-6968 [email protected] Joshua Korsen, Ph.D. 212-715-2886 [email protected] Matthew Keller, Ph.D. 212-856-5745 [email protected] Sara Nik, Ph.D. 212-916-3970 [email protected] Lander Egaña Gorroño, Ph.D. 212-916-3977 [email protected] Boosting IO Approach With New Collaboration; BLA Acceptance Expected Shortly Stock Data 7/15/2024 Price $2.51 Exchange…